Virtus ETF Advisers LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$226,000
+96.5%
6,118
+0.8%
0.09%
+109.3%
Q2 2022$115,000
-50.0%
6,068
-28.7%
0.04%
-58.3%
Q1 2022$230,000
+13.3%
8,516
-5.5%
0.10%
+33.8%
Q4 2021$203,000
+15.3%
9,015
+34.5%
0.08%0.0%
Q3 2021$176,000
-22.1%
6,703
-5.0%
0.08%
-17.2%
Q2 2021$226,000
-28.3%
7,056
-21.1%
0.09%
-30.1%
Q1 2021$315,000
+11.7%
8,947
+1.9%
0.13%
+13.7%
Q4 2020$282,000
+14.2%
8,783
+33.8%
0.12%
-10.0%
Q3 2020$247,000
-26.0%
6,564
-12.0%
0.13%
-17.7%
Q2 2020$334,0007,4630.16%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders